OB/GYN News - Bone loss related to Depo-Provera reverses after discontinuing therapy
Sunday, January 4th, 2009 Bone loss associated with depot medroxyprogesterone acetate was reversible in a prospective population-based cohort study.
In 183 nonpregnant, reproductive-age users of the injectable contraceptive, which is sold as Depo-Provera, bone density at the spine changed at an annualized mean rate of -0.87%, comp…
